Research Presentation Session

RPS 407 - The prostate and other glands

Lectures

1
RPS 407 - Incidence of thyroid dysfunction after iodine-based contrast medium administration and identification of risk factors

RPS 407 - Incidence of thyroid dysfunction after iodine-based contrast medium administration and identification of risk factors

04:48J. Carlqvist, Göteborg / Sweden

2
RPS 407 - Interobserver reproducibility of the PI-QUAL scoring system for prostate MRI quality: a pilot study from the NeuroSAFE PROOF trial

RPS 407 - Interobserver reproducibility of the PI-QUAL scoring system for prostate MRI quality: a pilot study from the NeuroSAFE PROOF trial

05:44F. Giganti, London / UK

3
RPS 407 - Evaluation of the diagnostic performance of biparametric MRI, with and without quantitative analysis of ADC values vs multiparametric MRI of the prostate

RPS 407 - Evaluation of the diagnostic performance of biparametric MRI, with and without quantitative analysis of ADC values vs multiparametric MRI of the prostate

05:33G. Carnicelli, Rome / Italy

4
RPS 407 - Assessing the role of radiomic features from high b-value DWI sequences in the early detection of clinically significant prostate cancer (PCa)

RPS 407 - Assessing the role of radiomic features from high b-value DWI sequences in the early detection of clinically significant prostate cancer (PCa)

05:04M. Mottola, Bologna / Italy

5
RPS 407 - Pharmacokinetic analysis of benign and malignant diseases of the prostate gland in MpMRI

RPS 407 - Pharmacokinetic analysis of benign and malignant diseases of the prostate gland in MpMRI

05:08R. Büyüktoka, Izmir / Turkey

6
RPS 407 - Can prostate biopsy sepsis be eliminated? A radiology departments experience with 215 outpatient transperineal prostate biopsies

RPS 407 - Can prostate biopsy sepsis be eliminated? A radiology departments experience with 215 outpatient transperineal prostate biopsies

05:06J. Power, Dublin / Ireland

PEP Subscription Required

This course is only accessible for ESR Premium Education Package subscribers.